Check b determine out the companies making headlines after the bell:
Shares of Red Hat surged hardly 5 percent after hours after the open-source software company narrated its fourth-quarter earnings. The company reported earnings per share and revenue that worst Wall Street expectations. Sales rose 23 percent year one more time year to $772 million in the fourth quarter.
AnaptysBio shares mustered over 12 percent post-market. The drug developer announced reliable peanut allergy treatment data on Monday afternoon. Analysis of the mid-stage annoyance data pointed to nearly half of patients treated showing peanut toleration.
Following AnapstysBio’s good news, shares of Aimmune Therapeutics demolish nearly 2 percent. Aimmune’s drug to treat peanut allergy in youngsters succeeded in a late-stage study in February.
SM Energy stock gained floor 2 percent in extended trading. The natural gas exploration company announced that it completed a then announced sale of the majority of its assets in the Powder River Basin for $500 million. The convention plans to use the proceeds for general corporate purposes, including debt reduction.